Stay updated on Talquetamab Dose Escalation in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.

Latest updates to the Talquetamab Dose Escalation in Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new record version was added for the talquetamab trial, documenting a study-status update and a new update date.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer version label changed from v3.7.2 to v3.8.0. The study record content is unchanged.SummaryDifference0.0%

- Check23 days agoChange DetectedA site-wide notice says NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a transition.SummaryDifference0.3%

- Check30 days agoChange DetectedThe footer's ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check37 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check51 days agoChange DetectedThe record history now includes a new Study Status entry added in September 2026. An older history entry from July 2026 was removed.SummaryDifference0.2%

Stay in the know with updates to Talquetamab Dose Escalation in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.